385 related articles for article (PubMed ID: 9371827)
21. HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence.
Kim DH; Langlois MA; Lee KB; Riggs AD; Puymirat J; Rossi JJ
Nucleic Acids Res; 2005; 33(12):3866-74. PubMed ID: 16027111
[TBL] [Abstract][Full Text] [Related]
22. Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts.
Davis BM; McCurrach ME; Taneja KL; Singer RH; Housman DE
Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7388-93. PubMed ID: 9207101
[TBL] [Abstract][Full Text] [Related]
23. Loss of MBNL1-mediated retrograde BDNF signaling in the myotonic dystrophy brain.
Wang PY; Kuo TY; Wang LH; Liang WH; Wang GS
Acta Neuropathol Commun; 2023 Mar; 11(1):44. PubMed ID: 36922901
[TBL] [Abstract][Full Text] [Related]
24. Myotonic dystrophy--a multigene disorder.
Larkin K; Fardaei M
Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):389-95. PubMed ID: 11719277
[TBL] [Abstract][Full Text] [Related]
25. DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1.
Pettersson OJ; Aagaard L; Andrejeva D; Thomsen R; Jensen TG; Damgaard CK
Nucleic Acids Res; 2014 Jun; 42(11):7186-200. PubMed ID: 24792155
[TBL] [Abstract][Full Text] [Related]
26. DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model.
Berul CI; Maguire CT; Aronovitz MJ; Greenwood J; Miller C; Gehrmann J; Housman D; Mendelsohn ME; Reddy S
J Clin Invest; 1999 Feb; 103(4):R1-7. PubMed ID: 10021468
[TBL] [Abstract][Full Text] [Related]
27. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
Ranum LP; Day JW
Curr Neurol Neurosci Rep; 2002 Sep; 2(5):465-70. PubMed ID: 12169228
[TBL] [Abstract][Full Text] [Related]
28. Celf1 regulates cell cycle and is partially responsible for defective myoblast differentiation in myotonic dystrophy RNA toxicity.
Peng X; Shen X; Chen X; Liang R; Azares AR; Liu Y
Biochim Biophys Acta; 2015 Jul; 1852(7):1490-7. PubMed ID: 25887157
[TBL] [Abstract][Full Text] [Related]
29. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities.
Seznec H; Agbulut O; Sergeant N; Savouret C; Ghestem A; Tabti N; Willer JC; Ourth L; Duros C; Brisson E; Fouquet C; Butler-Browne G; Delacourte A; Junien C; Gourdon G
Hum Mol Genet; 2001 Nov; 10(23):2717-26. PubMed ID: 11726559
[TBL] [Abstract][Full Text] [Related]
30. Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1.
Nutter CA; Kidd BM; Carter HA; Hamel JI; Mackie PM; Kumbkarni N; Davenport ML; Tuyn DM; Gopinath A; Creigh PD; Sznajder ŁJ; Wang ET; Ranum LPW; Khoshbouei H; Day JW; Sampson JB; Prokop S; Swanson MS
Brain; 2023 Oct; 146(10):4217-4232. PubMed ID: 37143315
[TBL] [Abstract][Full Text] [Related]
31. RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy.
Sobczak K; Wheeler TM; Wang W; Thornton CA
Mol Ther; 2013 Feb; 21(2):380-7. PubMed ID: 23183533
[TBL] [Abstract][Full Text] [Related]
32. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
[TBL] [Abstract][Full Text] [Related]
33. Expanded CUG repeats in
van Cruchten RTP; Wieringa B; Wansink DG
RNA; 2019 Apr; 25(4):481-495. PubMed ID: 30700578
[TBL] [Abstract][Full Text] [Related]
34. Triplet-repeat transcripts: a role for DNA in disease.
Singer RH
Science; 1998 May; 280(5364):696-7. PubMed ID: 9599147
[No Abstract] [Full Text] [Related]
35. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation.
Kuyumcu-Martinez NM; Wang GS; Cooper TA
Mol Cell; 2007 Oct; 28(1):68-78. PubMed ID: 17936705
[TBL] [Abstract][Full Text] [Related]
36. Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy.
Leger AJ; Mosquea LM; Clayton NP; Wu IH; Weeden T; Nelson CA; Phillips L; Roberts E; Piepenhagen PA; Cheng SH; Wentworth BM
Nucleic Acid Ther; 2013 Apr; 23(2):109-17. PubMed ID: 23308382
[TBL] [Abstract][Full Text] [Related]
37. Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties.
Groenen PJ; Wansink DG; Coerwinkel M; van den Broek W; Jansen G; Wieringa B
Hum Mol Genet; 2000 Mar; 9(4):605-16. PubMed ID: 10699184
[TBL] [Abstract][Full Text] [Related]
38. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.
Langlois MA; Lee NS; Rossi JJ; Puymirat J
Mol Ther; 2003 May; 7(5 Pt 1):670-80. PubMed ID: 12718910
[TBL] [Abstract][Full Text] [Related]
39. Myotonic dystrophy: RNA pathogenesis comes into focus.
Ranum LP; Day JW
Am J Hum Genet; 2004 May; 74(5):793-804. PubMed ID: 15065017
[TBL] [Abstract][Full Text] [Related]
40. Myotonic dystrophy and myotonic dystrophy protein kinase.
Ueda H; Ohno S; Kobayashi T
Prog Histochem Cytochem; 2000; 35(3):187-251. PubMed ID: 11064921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
